Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.99
-0.05 (-0.50%)
Mar 31, 2025, 2:25 PM EDT - Market open
Bioventus Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Bioventus stock have an average target of 15, with a low estimate of 13 and a high estimate of 17. The average target predicts an increase of 66.94% from the current stock price of 8.99.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bioventus stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 3 | 3 | 3 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +66.94% | Mar 17, 2025 |
JP Morgan | JP Morgan | Sell → Hold Upgrades $12 → $13 | Sell → Hold | Upgrades | $12 → $13 | +44.69% | Dec 17, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +66.94% | Nov 6, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +89.20% | Sep 27, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +33.56% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
570.52M
from 573.28M
Decreased by -0.48%
Revenue Next Year
605.29M
from 570.52M
Increased by 6.09%
EPS This Year
0.66
from -0.52
EPS Next Year
0.86
from 0.66
Increased by 29.44%
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 593.3M | 632.9M | 656.3M |
Avg | 570.5M | 605.3M | 631.3M |
Low | 553.4M | 583.1M | 612.5M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 3.5% | 10.9% | 8.4% |
Avg | -0.5% | 6.1% | 4.3% |
Low | -3.5% | 2.2% | 1.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.69 | 1.04 | 0.82 |
Avg | 0.66 | 0.86 | 0.79 |
Low | 0.64 | 0.70 | 0.76 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | 56.7% | -4.6% |
Avg | - | 29.4% | -8.2% |
Low | - | 4.9% | -11.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.